Page 28 - 10 Most Trusted Diagnostic Companies in India 2022
P. 28
FOCUS POINT
projects of NVNR Power and tinib oral capsules, for the treat- GOVERNMENT INITIATIVES tion and innovation infrastructure.
Infra in Hyderabad. The company ment of kidney cancer in India. Some of the initiatives
will acquire 26% share capital in taken by the Government to • In August 2021, Union Health
both companies with an US$ 1.5 • In February 2021, Natco Pharma promote the pharmaceutical Minister, Mr. Mansukh Manda-
million investment. The acquisi- launched Brivaracetam for the viya announced that an addi-
tion is expected to be completed treatment of epilepsy in India. sector in India are as follows: tional number of pharmaceutical
by the end of March 2021.
• In February 2021, the Russian • India could restart deliveries of companies in India are expected
• In February 2021, the Telan- Ministry of Health allowed Glen- COVID-19 shots to global vaccine- to commence manufacturing of
gana government partnered mark Pharmaceuticals to market sharing platform COVAX in Novem- anti-coronavirus vaccines by Octo-
with Cytiva to open a ‘Fast its novel fixed-dose combi- ber-December 2021 for the first ber-November 2021. This move is
Trak’ lab to strengthen the nation nasal spray in Russia. time since April 2021. The World expected to further boost the vacci-
biopharma industry of the state.
• In January 2021, the Central Health Organization (WHO), which nation drive across the country.
• In February 2021, Glenmark government announced to set up co-leads COVAX, has been pushing
Pharmaceuticals Limited launched three bulk drug parks at a cost of Rs. India to resume supplies for the • In June 2021, Finance Minister
SUTIB, a generic version of Suni- 14,300 crore (US$ 1,957 million) to programme, particularly after it Ms. Nirmala Sitharaman announced
tinib oral capsules, for the treat manufacture chemical compounds sent ~4 million doses to neigh- an additional outlay of Rs. 197,000
or active pharmaceutical ingre crore (US $26,578.3 million) that will
dients (APIs) for medicines and bours and allies in October 2021.
reduce imports from China. be utilised over five years for the
• In November 2021, PM Mr. pharmaceutical PLI scheme in 13
• PharmEasy received US$ Narendra Modi inaugurated the key sectors such as active pharma-
300 million in July 2021 from its first Global Innovation Summit of ceutical ingredients, drug interme-
existing investors after acquiring the pharmaceuticals sector. The diaries and key starting materials.
Thyrocare, the diagnostic firm. summit will have 12 sessions and
These funds will be utilised to over 40 national and international • As of August 31, 2021, the PLI
continue Thyrocare’s acquisition
process. After the transaction speakers deliberating on a range scheme received a good response
is completed, the online phar- of subjects including regulatory from the industry with a total
macy plans to float the company environment, funding for innova- of 278 applications. This is likely
on the Indian Stock Exchange. tion, industry-academia collabora to benefit 55 manufacturers.
|28 thecorporatereview.com | India | Vol. 3 | Issue 3 | March 2022 |29
